(Total Views: 131)
Posted On: 10/03/2019 10:20:45 AM
Post# of 36679
$SMMT News Article - Summit Therapeutics Reports Ridinilazole Significantly Improved Short and Longer-Term Quality of Life Measures in Patients with C. difficile Infection Compared to Standard of Care https://marketwirenews.com/news-releases/summ...11308.html
(0)
(0)
My Twitter: WhyteStocks
